Mumbai-based SeQuent Scientific has appointed Rajaram Narayanan as Managing Director and Chief Executive Officer, effective April 11, 2022. Narayanan, who has served in senior leadership roles across the pharmaceutical, consumer goods and services industries, succeeds Manish Gupta who will be stepping down effective 10 April 2022 after serving as MD and CEO of SeQuent for the past eight years. Gupta will continue to serve as a strategic advisor to the company until July 2022. 

Narayanan will oversee the company's next phase of growth and expansion. SeQuent is backed by global investment firm Carlyle. With over 25 years of experience, Narayanan has a strong track record of leading revenue and profitability growth across multiple industries including pharmaceuticals. He joins from Sanofi India, where he was the Managing Director and Country Chair for India. At Sanofi, he led the strategic reorientation of its India business operations, resulting in accelerated growth in key therapies and significant transformation of Sanofi’s market operations. Before this, he was Chief Marketing Officer at Airtel, India's leading telecommunications company. Narayanan started his career at Hindustan Unilever, where he held various leadership roles in India and other Asian markets for over 18 years, building and managing many iconic consumer brands.